Submitted by Anonymous (not verified) on 26 July 2024 - 11:00
Human medicines European public assessment report (EPAR): Ituxredi, rituximab, Status: Opinion
Source:
Human medicines European public assessment report (EPAR): Ituxredi, rituximab, Status: Opinion